PLoSONE 12(9):e0184986.https://doi.org/10.1371/journal.pone.0184986
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
Version 2, updated 17 March 2016
Policy and service delivery guidelines for linkage to care, adherence to treatment and retention in care
February 2016
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Meeting report
Geneva, 16-18 November 2016
Technical Report
AIDS Medicines and diagnostics service
September 2016
Public Report
PQMC 0001-001-04 WHO PQMC Public Report November/2016, version 8.0
Dispatches
DOI: http://dx.doi.org/10.3201/eid2203.151607
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 22, No. 3, March 2016
• PrEP is highly effective in preventing the sexual transmission of HIV.
• For PrEP to work well, it’s important to take the pills regularly.
• While PrEP can prevent HIV, it does not protect against other sexually transmitted infections.
Session V: Regulatory & quality assurance aspects
Update on prequalification of ARVs and regional harmonisation of medicine registration
Deusdedit K. Mubangizi
Group Lead, Inspections, WHO-PQT E-mail: mubangizid@who.int
Acknowledgements:
• Matthias Stahl
• Milan Smid
• Antony Fake
...• Jacqueline Sawyer
• Iveta Streipa
D-Building – UNAIDS
Kofi A. Annan Meeting Room
Wednesday, 9 March 2016 11:15 – 11:30
more
Boniface Dongmo-Nguimfack WHO/HIV/SIP
08. March 2016
HIV testing
Policy Brief
July 2015
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...treatment –or what some have dubbed the “test and treat” model –is backed by the latest research.
more
HIV testing
Policy Brief
July 2015